ArticleCancer medicine2024

Unveiling CKS2: A Key Player in Aggressive B-Cell Lymphoma Progression and a Target for Synergistic Therapy.

Fenling Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.